Introducing the 2024 ANDA Litigation Intelligence Report: Insights into the Competitive Pharmaceutical Landscape
As the pharmaceutical industry continues to face an ever-changing legal environment, staying informed about trends in ANDA litigation has never been more crucial. At Patexia, we are committed to providing stakeholders with the most reliable and up-to-date intelligence. We are excited to announce the release of our 2024 ANDA Litigation Intelligence Report.
This report is an essential resource for anyone involved in the pharmaceutical sector—whether you’re managing litigation, developing market entry strategies, or navigating complex patent disputes. Our thorough analysis offers a clear picture of the current state of ANDA litigation, empowering stakeholders to stay ahead in an increasingly competitive environment.
What’s Inside the 2024 Report?
The fifth edition of the Patexia ANDA Litigation Intelligence Report is our most detailed and data-rich analysis yet, covering a five-year period from July 1, 2019, through June 30, 2024. This report dives deep into the intricacies of ANDA litigation, providing a comprehensive overview of filing trends, patent involvement, and jurisdictional distributions. With over 1,321 ANDA cases analyzed, it offers key metrics such as the patent-to-case ratio, case complexity, and insights into how these factors are shaping the current legal landscape.
Our team has meticulously reviewed all judgments and decisions to calculate activity and success scores for each entity involved, including law firms, companies, judges, and attorneys. The result is a set of rankings that provide invaluable guidance for those engaged in ANDA litigation, helping them make informed decisions based on the most accurate data available.
Using advanced computational methods and machine learning, we’ve assessed the performance of key players, offering rankings based on activity and success scores. Additionally, the report includes a detailed PDF and an accompanying Excel file, making it easy to access extensive data, including rankings, lateral moves, and insights on local counsel and judges.
Stay Ahead in ANDA Litigation
The 2024 ANDA Litigation Intelligence Report will be available tomorrow, reaffirming our commitment to continually refining our methodologies and expanding our data sets to provide even more accurate and actionable insights in future editions. As the pharmaceutical industry evolves, we’ll be here to guide you with the latest intelligence and analysis.
Don’t miss your chance to gain access to this essential resource. Whether you're a law firm, a pharmaceutical company, or an IP professional, this report will provide the insights you need to succeed in the complex world of ANDA litigation.
Stay informed, stay competitive—explore the full report and discover the leading players in ANDA litigation. The 2024 ANDA Litigation Intelligence Report will be available for purchase and download starting tomorrow at: 2024 ANDA Litigation Intelligence Report | Patexia.